About Inquis Medical
Inquis Medical is a Healthcare company based in Redwood City (United States) founded in 2019. Developer of medical device for the treatment of peripheral thrombectomy. Inquis Medical has raised $115 million across 2 funding rounds from investors including Marshall Wace, ShangBay Capital and Yu Galaxy. Its chief executive, as recorded, is Vahid Saadat. Inquis Medical offers products and services including AVENTUS Thrombectomy System and AVENTUS Clot Management System. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Orchestra BioMed and Synaptic Medical; 2 of its 2 listed competitors have raised funding.
Company details
Inquis Medical was founded in 2019 and is headquartered in Redwood City, United States. Focus is placed on the development of medical devices targeted at peripheral thrombectomy procedures within the healthcare sector. Operations involve engineering solutions for vascular interventions, with emphasis on device efficacy for clot removal. The company is led by CEO Vahid Saadat, and activities are conducted primarily in the United States medical device industry.
- Headquarters Redwood City, United States
- SectorsHealthcare
- Website inquismedical.com
- Social LinkedIn
- Total Equity Funding$115M (USD)
in 2 rounds
- Latest Funding Round$75M (USD), Series C
Jan 2026
- InvestorsMarshall Wace
& 4 more
Products & Services of Inquis Medical
Inquis Medical offers a comprehensive portfolio of products and services, including AVENTUS Thrombectomy System and AVENTUS Clot Management System.
Device for non-surgical removal of blood clots in vasculature.
System for autologous blood transfusion during procedures.
Funding Insights of Inquis Medical
Inquis Medical has successfully raised a total of $115M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $75 million completed in January 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $115M
- Total Rounds 2
- Last Round Series C — $75M
- First Round $40M
(Nov 2024)
- Investors Count 5
All 2 funding rounds of Inquis Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | $75M | Series C | – | – | – |
| Nov 2024 | $40M | Series B | – | Marshall Wace |
5 investors in total: 4 institutional and 1 angel.
Investors in Inquis Medical
Inquis Medical has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Marshall Wace, ShangBay Capital and Yu Galaxy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Long-short equity strategies are managed through specialized hedge funds. | 1997 | mwam.com | London, United Kingdom | |
| shangbaycapital.com | ||||
Venture capital investments are made in innovative founders by Yu Galaxy. | 2020 | yugalaxy.com | Silicon Valley, United States | |
PL Pierre Lamond | Veteran VC, early investor in Indian startups, ex-Sequoia Capital partner | unknown_c120e20c79884855a |
Investor details for Inquis Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Inquis Medical
1 people are tracked at Inquis Medical (1 in leadership).
| Name | Role | Group |
|---|---|---|
Vahid Saadat | CEO | Leadership |
Complete people profiles for Inquis Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Inquis Medical
3 dated milestones of Inquis Medical across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Inquis Medical is founded.
- Funding First funding round of $40.0M.
- Funding Latest funding round, Series C, of $75.0M.
Competitors of Inquis Medical
Inquis Medical has 2 listed competitors in our database, 2 of them funded. They include Orchestra BioMed and Synaptic Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| orchestrabiomed.com | 2017 | New Hope, United States | $205.88M | Medical devices for hypertension and atherosclerosis treatment are developed. | ||
| synapticmed.com | 2005 | Lake Forest, United States | $60M | Medical devices for cardiac arrhythmias and cardiovascular diseases are developed. |
Detailed competitors of Inquis Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Inquis Medical
The website of Inquis Medical (inquismedical.com) receives about 3.6K visits a month.
- Monthly visits3.6K
▲ 113% vs previous month
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Inquis Medical (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Inquis Medical
Complete news archive for Inquis Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inquis Medical
Inquis Medical was founded in 2019 and raised its 1st funding round 5 years after it was founded.
Inquis Medical is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Vahid Saadat is the CEO of Inquis Medical, as recorded in our data.
Inquis Medical is a funded company, having raised a total of $115M across 2 funding rounds to date. The company's 1st funding round was a Series B of $40M, raised on Nov 2024.
Inquis Medical was founded in 2019 and is headquartered in Redwood City, United States. Focus is placed on the development of medical devices targeted at peripheral thrombectomy procedures within the healthcare sector. Operations involve engineering solutions for vascular interventions, with emphasis on device efficacy for clot removal. The company is led by CEO Vahid Saadat, and activities are conducted primarily in the United States medical device industry.
Inquis Medical's top competitors include Orchestra BioMed and Synaptic Medical.
Inquis Medical offers AVENTUS Thrombectomy System and AVENTUS Clot Management System.
Inquis Medical has 5 investors. Key investors include Marshall Wace, ShangBay Capital, Yu Galaxy, Pierre Lamond, and EnPointe Ventures.